Liver Disease Clinical Trials in Chicago

Showing 1-20 of 78 trials

Extracellular RNA Markers of Liver Disease and Cancer

NCT02908048

The study will examine and evaluate the use of extracellular RNA in blood as markers for the diagnosis of liver disease or cancer, and as markers for prediction of response to treatment or recurrence of cancer after surgery

Hepatocellular CarcinomaBiliary Tract CancerCirrhosis+1 more

Mayo Clinic1,865 participantsStarted Jul 2014

Jacksonville, Florida, United States • Chicago, Illinois, United States • Rochester, Minnesota, United States +1 more locations

Active Not RecruitingPhase 22.2 miles

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

NCT02968810

This phase II trial studies how well simvastatin works in preventing liver cancer in patients with liver cirrhosis. Simvastatin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

CirrhosisHepatocellular Carcinoma

National Cancer Institute (NCI)52 participantsStarted Jun 2017

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +2 more locations

Enrolling By Invitation2.2 miles

An Observational Study of Patients With Chronic Liver Disease

NCT05744713

TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).

Chronic Liver DiseaseCirrhosis

Target PharmaSolutions, Inc.500,000 participantsStarted Feb 2024

Los Angeles, California, United States • Redwood City, California, United States • Washington D.C., District of Columbia, United States +7 more locations

Extracellular RNA Markers of Liver Disease and Cancer

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

An Observational Study of Patients With Chronic Liver Disease

Liver Disease Trials in Other Cities

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Phase 2b Study of GSK4532990 in Adults With NASH

DILIN - Prospective Study

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Liver Cirrhosis Network Cohort Study

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Social & Contextual Impact on Children Undergoing Liver Transplantation

A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK

Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

Other Conditions in Chicago